How to identify hypertensive patients at high cardiovascular risk? The role of echocardiography.

about

How to identify hypertensive patients at high cardiovascular risk? The role of echocardiography.

Item

http://www.wikidata.org/entity/Q38370155

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

How to identify hypertensive p ...... The role of echocardiography.

@en

type

Item

label

How to identify hypertensive p ...... The role of echocardiography.

@en

prefLabel

How to identify hypertensive p ...... The role of echocardiography.

@en

P1476

How to identify hypertensive p ...... The role of echocardiography.

@en

P2093

Carla Sala

http://www.w3.org/2001/XMLSchema#string

Cesare Cuspidi

http://www.w3.org/2001/XMLSchema#string

Guido Grassi

http://www.w3.org/2001/XMLSchema#string

Marijana Tadic

http://www.w3.org/2001/XMLSchema#string

P2860

Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study.

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.

Treatment of diastolic dysfunction in hypertension.

Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review.

Prevalence of echocardiographic left-atrial enlargement in hypertension: a systematic review of recent clinical studies.

Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis.

Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.

Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril.

P2888

s40292-015-0079-2

P304

113-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40292-015-0079-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273324445

http://www.w3.org/2001/XMLSchema#string

P698

25749858

http://www.w3.org/2001/XMLSchema#string

P921

echocardiography